Updates in the Journey for Disease-Modifying Therapies for Alzheimer Disease

Target Audience
This online educational activity is directed toward neurologists, primary care physicians, physician assistants, and nurses specializing in neurologic disorders.

Program Overview
This online, on-demand virtual symposium brings together renowned experts in Alzheimer disease, the most common cause of dementia among older adults. In this educational program, faculty discuss current and emerging biomarkers that can aid in earlier diagnosis. Current treatments that address symptoms will be reviewed. Pathophysiologic targets for agents in clinical trials are described, followed by presentation of data on second-generation immunotherapies. The program will conclude with practical approaches to manage comorbidities and improve quality of life for both patients and caregivers, along with the latest evidence for a healthy-brain lifestyle.

This educational activity is an archive of the live virtual symposium held on November 24, 2020.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Explain neurodegenerative alterations that are considered the hallmarks of AD versus different neurodegenerative disorders
Implement screening and diagnostic protocols in clinical practice to ensure early detection of AD
Analyze key data on new and emerging treatment options for AD to properly educate patients and impacted caregivers
Construct team-based strategies to improve coordination of care for patients with AD